• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: Some nursing homes refuse to use COVID-19 rapid antigen tests

Report: Some nursing homes refuse to use COVID-19 rapid antigen tests

November 9, 2020 By Sean Whooley

Abbott's BinaxNow COVID-19 Ag Card COVID-19 corona virus
Abbott’s BinaxNow COVID-19 Ag Card [Image courtesy of Abbott]
Many rapid COVID-19 tests are going unused in nursing homes as there reportedly remain concerns over accuracy in detecting the virus.

The Wall Street Journal reports that a federal survey of nursing homes found that 30% of 13,150 facilities that had rapid testing equipment for at least two weeks did not use it to test a single resident or staff member, even when regulations from CMS required them to do so.

Barbara Klick, chief executive of Sholom Community Alliance, which uses a lab to test staffers at its two nursing homes in Minnesota, told WSJ that using the rapid testing equipment sent by the government requires too much staff time, with false-negative and false-positive result potential making users wary of reliability.

Antigen tests being sent to the nursing homes include the Sofia 2 from Quidel (received emergency use authorization in May), the antigen test from Becton Dickinson (EUA in July) and the Abbott BinaxNow (EUA in August). The tests from Quidel and BD require the use of a machine to read the results, while Abbott’s is designed like a pregnancy test, with results available for reading off the testing card. Quidel and BD’s tests were sent to homes in July and were followed by Abbott’s shortly after it received EUA.

In addition to homes that didn’t use the devices, WSJ said another 16% reported using the tests on fewer than 20 residents and staff members. Also, 48% of the homes reported that they hadn’t used their rapid testing equipment in the most recent week included in the data (week ended Oct. 25), with 41% of homes that were required to test staff at least once a week saying they hadn’t used it in the most recent week. Those homes said they were waiting a day or more for lab results instead.

Quidel told WSJ that it is offering a “multifaceted approach” for training and supporting those using its products, while BD told the outlet that testing, including rapid antigen tests, plays an “essential role” in helping to stop the spread of COVID-19, and most nursing homes are getting regular reorders of its tests.

An Abbott spokesperson told MassDevice that widespread and affordable rapid antigen testing helps to slow the spread of the virus and get people who are most likely to be infectious into quarantine.

“Abbott has begun shipping BinaxNOW to HBCUs, disaster areas to support relief efforts, nursing homes and assisted living centers across the U.S., and the states,” a company statement shared by an Abbott spokesperson said, referring in part to historically Black colleges and universities. “Abbott’s BinaxNOW rapid antigen test, when administered by a healthcare professional and used as intended within the first seven days of symptom onset, provides consistent and reliable results. And, unlike other rapid antigen tests, Abbott’s do not require any additional equipment.  We have worked with nursing homes proactively to ensure they have the resources needed to best deploy BinaxNOW, including conducting webinars and reaching out to facilities individually.”

Filed Under: Business/Financial News, Contract Manufacturing, Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: Abbott, becton dickinson, coronavirus, COVID-19, Quidel Corp.

More recent news

  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech
  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy
  • Elucent Medical wins FDA breakthrough nod for in-body spatial intelligence system
  • EndoQuest Robotics completes first cases in pivotal surgical robot trial
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy